Outcomes of COVID-19 in Patients with Skin Cancer.

MedStar author(s):
Citation: British Journal of Dermatology. 185(3):654-655, 2021 09.PMID: 33837520Institution: MedStar Washington Hospital CenterDepartment: Dermatology | Dermatology ResidencyForm of publication: Journal ArticleMedline article type(s): LetterSubject headings: *COVID-19 | *Skin Neoplasms | Humans | Risk Factors | SARS-CoV-2Year: 2021ISSN:
  • 0007-0963
Name of journal: The British journal of dermatologyAbstract: The effect of skin cancer diagnosis on the risk of adverse outcomes from COVID-19 remains unknown. Few studies have shown cancer patients with COVID-19 have higher rates of mortality and hospitalizations compared to those without cancer, perhaps due to a combination of delayed diagnosis and pre-existing comorbidities from chemotherapy and radiation treatments.1. Copyright This article is protected by copyright. All rights reserved.All authors: Deng M, Hussain A, Pakhchanian H, Raiker ROriginally published: British Journal of Dermatology. 2021 Apr 10Fiscal year: FY2021Digital Object Identifier: Date added to catalog: 2021-06-07
Holdings
Item type Current library Collection Call number Status Date due Barcode
Journal Article MedStar Authors Catalog Article 33837520 Available 33837520

The effect of skin cancer diagnosis on the risk of adverse outcomes from COVID-19 remains unknown. Few studies have shown cancer patients with COVID-19 have higher rates of mortality and hospitalizations compared to those without cancer, perhaps due to a combination of delayed diagnosis and pre-existing comorbidities from chemotherapy and radiation treatments.1. Copyright This article is protected by copyright. All rights reserved.

English

Powered by Koha